However, both SLC2A1 (FDR < 0.01) and SLC2A3 (FDR < 0.001) genes—associated with higher glucose uptake and oncogenic growth [12, 45, 46]—are markedly overexpressed in BRAF- (vs RAS)-like tumours (Fig. 1b). The gene discussed is BRAF; the disease is neoplasm.